AGTR1 and Hypertension: In an attempt to unravel the mechanisms underlying the hypertension induced by the most potent RTKI, cediranib, we evaluated the effects of pretreatment with the AT1R antagonist losartan (28) on the cardiovascular responses to cediranib.